GT BIOPHARMA, INC. — Cash Flow Charts
44 quarters of history · ending 2021-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-1552.0% -$3M
$-4M
Free Cash Flow↓-1552.0% -$3M
$-4M
Investing Cash Flow
$0
Financing Cash Flow↓-88.6% -$1M
$137K
Capex
$0
Dividends Paid
—
Stock-Based Comp↑+987.8% +$2M
$2M
D&A
$0
SBC Allocated Expense↑+987.8% +$2M
$2M